Daria Yanez
Obstetrics & Gynecology · Media, PANPI 1790754786
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 25.7% of the total.
Across 123 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$591
- Exeltis, USA Inc.$210
- Therapeuticsmd, Inc.$209
- Evofem Biosciences, Inc.$176
- Mayne Pharma Commercial LLC$133
- Mylan Pharmaceuticals Inc.$114
- plus $871 from 21 others
What the payments were for
- Food & beverage$2,27599%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $591 |
| Exeltis, USA Inc. | 10 | $210 |
| Therapeuticsmd, Inc. | 11 | $209 |
| Evofem Biosciences, Inc. | 8 | $176 |
| Mayne Pharma Commercial LLC | 6 | $133 |
| Mylan Pharmaceuticals Inc. | 5 | $114 |
| Agile Therapeutics, Inc. | 4 | $92 |
| Coopersurgical, Inc. | 5 | $84 |
| Avion Pharmaceuticals | 6 | $82 |
| Organon | 3 | $82 |
| Myovant Sciences Inc. | 4 | $70 |
| Amgen | 4 | $67 |
| Bayer | 2 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Astellas Pharma US Inc | 3 | $44 |
| Urovant Sciences Inc | 2 | $36 |
| Dysis Medical, Inc. | 2 | $32 |
| Roche Diagnostics Corporation | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Millicent US Inc | 1 | $22 |
| Baxter Healthcare | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Pfizer | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Covidien LP | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Minerva Surgical, Inc | 1 | $12 |
How this compares
$2,303 in reported general payments places this provider in the 85th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 15 | $1,259 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Media
- Stephen KlaskoPhiladelphia$2.2M
- Stephanie SoberPhiladelphia$1.8M
- Barry JacobsonGlen Mills$302K
- Timothy GrubeFrackville$260K
- Russell StankiewiczLewisburg$202K
- Jamille Nagtalon-RamosPhiladelphia$183K
- Timothy DeimlingMechanicsburg$182K
- Gerald HarkinsMechanicsburg$140K
- Kirthik ParthasarathyWest Reading$103K
- Catherine ChappellPittsburgh$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.